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Abstract 
The effects of adrenocorticotrophic hormone (4 lU/kg 
ACTH) and cycloheximide (2.5 mg/ml/kg CXM) on retention of 
a lone-way avoidance task were investigated in 100 day old 
rats of the SHS genetic line. There were 5 drug groups with 
16 rats per group. The different drug groups were injected 
30 minutes before training with either saline, CXM, ACTH, 
CXM plus ACTH, or CXM followed by ACTH immediately after 
training. Following the one-way avoidance training session 
the rats were tested for retention. Half of the rats from 
each drug group were tested 1 hour after training, and the 
other half were tested 5 hours after training. Retention 
was measured by extinction in terms of the number of avoid- 
ance responses and response latency. It was found that CXM 
impaired retention 5 hours after training; that ACTH did 
not influence retention either 1 or 5 hours after training; 
and that both pre and post training injections of ACTH count- 
eracted the amnesic effect of CXM 5 hours after training. 
The results are discussed in terms of (a) how ACTH counter- 
acted CXJ^i’s amnesic effect by stimulating the release of the 
neurotransmitter substances norepinephrine and dopamine, and 
thereby preventing neural blockage; and (b) how CXM's 
inhibitory effect on corticosteroid levels is dissociable 




Learning new information, retrieving an old idea, or 
recalling a thought all require certain biochemical 
reactions to occur within the brain. Conversely, the 
inability to perform these cognitive memory tasks suggest 
certain biochemical dysfunctioning; and this suggests that 
relationships exist between certain biochemical processes 
and memory. 
The experimental study of the biological basis of memory 
is complicated in many respects because one is never sure 
the experimental techniques of drug intervention, brain 
stimulation, ablation or lesioning, used to intervene on 
memory do not exert non-specific effects on other bio- 
chemical processes, on locomotor activity, or on behavioral 
responses. In addition, there are other aspects of- the 
memory process to consider: does the experimental manip- 
ulation disrupt memory consolidation from short to long term 
memory? does it block recall? or does it inhibit the 
expression of memory by stimulating various defense 
mechanisms? 
The present research investigated the biochemistry of memory 
by experimentally inducing amnesia in rats by injecting an 
amnesia-inducing drug. Much evidence indicates that 
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experimental amnesia results from either protein synthesis 
inhibition at time of learning, or from adrenergic depletion 
at time of initial memory processing (research reported 
later). Therefore, a protein synthesis inhibiting drug 
(cycloheximide) (Squire & Barondes, 1972) was used to 
induce amnesia of avoidance task in rats. In addition, 
an adrenergic stimulating drug (adrenocorticotrophic 
hormone, research reported later), was given in combination 
with cycloheximide to determine if the amnesia could be 
counteracted. If so, then the findings would suggest that 
the adrenergic system is involved in the memory process. 
Research literature relating to the biology of memory is 
reported below. The review examines evidence implicating 
the role of protein synthesis in memory, the dissociation 
of drug induced non specific side-effects from amnesia, 
the involvement of adrenergic activity in relation to 
retention, the effects of peripheral changes on retention, 
and the interaction between the adrenergic system and the 
pituitary-adrenal system. And finally, the rationale of 
the present experiment is described. 
Review of Literature 
Mice injected with puromycin (PUR) - a protein synthesis 
inhibitor - 5 hours before training on an avoidance task 
3 
showed normal retention 15 minutes after training and 
impaired retention 3 hours after training (Barondes & Cohen, 
1966). The authors suspected that because PUR inhibited 
protein synthesis this was the cause of poor retention. The 
fact that retention was not disrupted 25 minutes after training, 
but was impaired 3 hours, after, suggests that protein systhesis 
may not be required for short term retention, but is needed 
for long term retention. 
In other experiments, different protein synthesis inhibitors 
were used, and similar results were found. Acetoxycyclo- 
heximide (AXM) administered to mice 5 hours before training 
on an avoidance learning task caused no retention deficits 
3 hours after training; however, there were deficits 6 
hours after training which even lasted over the ensuing 
week (Barondes & Cohen, 1967). Cychoheximide (CXM) adminis- 
tered to mice 30 minutes prior to training impaired reten- 
tion 3 hours after training (Squire & Barondes, 1972); and 
similarily, CXM administered to rats 30 minutes prior to 
training impaired retention up to 24 hours after training 
(Schmaltz & Delerm, 1974). 
The results indicate that inhibition of protein synthesis 
disrupts long term retention in both mice and rats, and that 
this effect is found whether the drugs are administered 
30 minutes or 5 hours before training. Interestingly, 
the drugs do not disrupt retention when given after train- 
ing, which suggests protein synthesis is essential 
during acquisition (for review of drug induced amnesia, 
see Barraco & Stettner, 1976; Classman, 1969; Squire & 
Davis, 1981). 
One must be careful not to interpret the amnesic effect 
induced by these drugs solely on the premise that it is 
caused by protein synthesis inhibition. Other findings 
suggest that drug induced amnesia may originate from 
changes in neural-electric activity, locomotor activity, 
aversive conditioning, or the adrenergic system. 
Flexner & Flexner (1966) found that the combined effect of 
AXM and PUR given one hour after training did not impair 
retention when tested 12 hours after training, even though 
the combined injection caused double the amount of protein 
synthesis inhibition. This is a contradictory finding, 
and it is possible that unique differences exist between 
PUR'S effect and that of CXM. The effect of PUR differs 
from that of AXM and CXM in several ways. PUR causes an 
amnesic effect when injected after training, whereas CXM 
and AXM do not (Barraco & Stettner, 1976). PUR causes an 
abnormal amount of electrical activity within the brain. 
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(i.e. PUR induces epileptiform discharges within the brain, 
Cohen & Barondes, 1967), whereas CXM does not. 
The question of whether amnesic inducing drugs cause 
behavioural changes that mimic amnesia, as opposed to 
actually changing biochemical memory processes, has been 
investigated. It is suggested that these drugs either in- 
hibit locomotor activity, or create aversive associations to 
the test environment, and as such, make an animal's 
response rate appear as though there was memory blockage. 
Experimentally testing whether an amnesic drug is exerting 
its effect on a particular biochemical system presumed to 
Underlie amnesia, or if it's exerting non-specific side 
effects on locomotor activity, is important in order to 
correctly link cause and effect. Various experimental 
designs havelbeen used which demonstrate the effect of CXM 
on locomotor activity, or on aversive conditioning, to be 
dissociable from CXM's amnesic effect. 
Quartermain & Botwinick (1975), demonstrated that retention 
of an avoidance motivated, or food motivated, discrimination 
task was significantly lower for CXM treated animals, than 
it was for saline treated control animals. However, on 
reversal training the control group displayed significantly 
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less ability to learn the reverse task, in comparison to 
the CXM treated animals. Presumably, the CXM group were 
amnesic to the first task; whereas, the control group was 
experiencing proactive interference. Furthermore, these 
results suggest that drug effects on locomotor activity or 
aversion does not interact with learning. 
Similarly, Nagelberg & Nagy (1977), found that pretesting 
injection of CXM into animals treated with saline at time 
of training did not affect retention; therefore, CXM's 
immediate effect on activity levels (i.e. hyperactivity. 
Squire & Barondes, 1972) did not interact with CXM's effect 
on retention. 
The effect of CXM on activity levels is that it immediately 
causes hyperactivity, which then subsides to a normal level 
of activity at time of training, and then develops into 
depressed locomotor activity that lasts up to 24 hours 
past training (Day, Overstreet & Schiller, 1977; Squire & 
Barondes, 1972). Logically, one would predict the amnesic 
effect of CXM to be caused by the locomotor depression; how- 
ever, this conclusion is false. Segal, Squire & Barondes 
(1971) demonstrated that CXM, and its derivative isoGXM 
both cause comparable locomotor depression, but isoCXM 
does not cause amnesia. And furthermore. Day, et.al. (1977) 
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have shown that CXM induced retention impairment for a 
conditioned avoidance response is improving 12 hours after 
training, whereas locomotor depression lasts up to 24 hours 
after training. Therefore, retention is improving despite 
there being significant locomotor depression. 
In another experiment by Davis, Rosenzweig, Bennet & Squire 
(1980), they found that large doses of ansiomycin (ANI) 
(120 mg/kg) injected 5 hours prior to training caused signif- 
icantly greater locomotor depression at time of training, 
than did a smaller dose of ANI (20 mg/kg) injected 20 
minutes prior to training; and that the lower dose caused 
more significant amnesia. 
The fact that CXM is used as either an agricultural fungi- 
cide or a rodent repellant (large doses) suggests that by 
using it one may induce debilitating aversive side effects 
which mimics amnesia. Experimental evidence counters this 
point, and demonstrates that CXM's effect on retention is 
distinct from its effect on aversive conditioning. 
For instance. Schmaltz & Clement-Forestier (1977) demon- 
strated that the combination of CXM treatment and forced 
shock administered to rats while in the training apparatus 
caused significantly poorer learning when trained 1 day later. 
8 
but there was no effect on learning when trained 3 weeks 
later; hence, no aversive associations. 
Similarly, Squire, Emanuel, Davis & Deutsch (1975) suggested 
that CXM's effect on aversive conditioning is separate from 
amnesic effects, because lithium chloride treatment causes 
aversive associations similar to CXM, but it does not affect 
memory. 
other possible artifacts of the experimentation that may 
interact with the amnesic effect are the effects of the 
drugs on learning, and the number of training trials given. 
Segal, Squire & Barondes (1972) found normal learning curves 
for both saline control groups and GXM groups. However, as 
the number of trials increased beyond 21, the effect of CXM 
became noticeable, and less acquisition resulted. In contrast, 
the effect of CXM in combination with a higher number of 
training trials was negligible, that is, retention was equal 
to that of the control group. 
Separating the effects of protein synthesis inhibitors on 
retention from their non-specific side effects, is important 
because it suggests that protein synthesis is the biological 
process underlying the amnesic effect, as suggested by 
Squire & Barondes, (1972). 
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Apart from the. interpretation that the amnesic effect of 
CXM results from protein synthesis inhibition, is the idea 
that CXM also exerts its effect by altering the level of 
catecholamines. By decreasing the level of the catechol- 
amines norepinephrine (NE) and dopamine (DA) one effectively 
reduces the neurotransmitter substances essential for the 
processing or transmission of memory related neural impulses. 
In one particular study, Flexner, Serota & Goodman (1973), 
demonstrated that CXM inhibited in vitro tyrosine hydr- 
oxylase activity, which is involved with the rate limiting 
step in the production of NE and DA. Hence, these authors 
argued that in addition to CXM's effect on protein synthesis, 
its effect on catecholamines is also responsible for 
amnesia. In contrast to this position are the findings by 
Squire, Kucenski & Barondes (1974), who found that CXM does 
inhibit tyrosine hydroxylase (11 - 13%) within 30 - 90 
minutes after injection, however , more substantial 
inhibition of tyrosine hydroxylase by injection of alpha- 
methyl-para-tyrosine (o<*MPT) did not cause amnesia. And these 
authors argue that the effects of CXM on the adrenergic 
system are not directly related to CXM's effect of retention. 
However, Quartermain & Botwinick (1975) did find thatck-MPT 
caused retention deficits when administered 3 hours prior 
to training, similar to that induced by CXM. 
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Although these findings confront each other, there is an 
abundance of empirical evidence indicating the adrenergic 
system is involved in the memory process. Experiments have 
demonstrated that injection of catecholamines directly, 
Catecholamine antagonists, or catecholamine agonists, all 
have an effect on retention. 
Haycock, van Buskirk, Ryan & McGough (1977), found that 
immediate post training injections of either ME or DA en- 
hanced retention of passive avoidance learning for step 
through latency and lick latency. Similar enhancing effects 
for retention have been found using the drugs corticosterone 
and hydrocortisone (Flood,Vidal, Bennet, Orme, Vasquez & 
Jarvik, 1978), and once again for NE and DA (Gold & van 
Buskirk, 1976b), and for ACTH (Bohus, 1971; Gold & van Buskirk, 
1976a; Sands & Wright, 1979). 
In many experiments it's been demonstrated that certain 
catecholamine antagonists disrupt retention, as does CXM, 
and these behavioural deficits can be counteracted by admin- 
istering catecholamine agonists. For instance, CXM induced 
amnesia for a multiple trial appetative spatial discrim- 
ination task is reversed by administering the norE receptor 
stimulator clonindine prior to training, up to 1 hour after 
training, and up to 3 hours prior to retention testing. 
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(Quartermain, Freedman, Botwinick & Gutwein, 1977) 
Similarly, injection of amphetamine right after training 
also counteracted CXM induced amnesia when tested up to 72 
hours later (Quinton & Bloom, 1975). 
The combination of catecholamine antagonists and agonists 
is counteractive in the sense they offset each other's 
effect on retention. Hamburg & Kerr (1975) demontrated that 
the dopamine beta hydroxylase inhibitor DDC impaired re- 
tention when injected 30 minutes prior to training or testing; 
and its amnesic effect is reversed by injection of the NE 
precursor DOPS 1 hour prior to DDC injection. However, Bloom 
(1975) did not find d-amphetamine injections post training to 
reverse DDC induced amnesia. 
Other experiments have demonstrated that the amnesic 
effect caused by injecting the dopamine beta hydroxylase 
inhibitor drug FLA-63 prior to training on a food motivated 
spatial discrimination task was counteracted by administration 
of the monoamino oxidase inhibitor drug pargyline 2 hours 
prior to retention test (Botwinick, Quartermain, Freedman & 
Hallock, 1977). And similarly, injection of I’tryptophan or 
corticosterone reversed CXM induced amnesia (Day, et.al., 
1977) . 
An interesting finding in relation to the enhancing effect 
of ACTH on retention, is that it operates in an inverted-U 
dose response curve, and is time dependent. Injections of 
ACTS at .03 and .3 lU/rat immediately after training en- 
hanced retention, whereas doses less than .03 or greater than 
3.0 lU/rat impaired retention (Gold & van. Buskirk, 1976 a,b) . 
Similarly, Sands & Wright (1979) found that injections of 
ACTH in rats at a dosage 1 lU/kg disrupted retention; 1 lU/kg 
immediately after training enhanced retention; doses of 10 or 
100 lU/kg did not significantly affect retention; and doses 
greater than 1000 lU/kg impaired retention. And furthermore, 
for ACTH to effectively enhance retention it has to be 
injected within 2 hours after training. 
Biochemically, ACTH is thought to excite central nervous 
system (CNS) activity by promoting a greater interaction 
between neurotransmitters and appropriate neural receptors 
(Flood, et.al., 1978), and this excitation is thought to 
increase NE turnover by stimulating a higher metabolism of 
NE from DA (Dunn, 1980). 
In addition to the biochemical effects of these protein 
synthesis inhibitor drugs on the central nervous system are 
their effects oh the peripheral nervous system, (i.e. the 
pituitary-adrenal system). Amnesic drugs induce protein 
synthesis inhibition within the adrenal glands, and thereby 
cause a reduction in the release of corticosteroids, accord- 
ing to Nakajiraa (1976). Nakajima (1975) suggested the 
amnesic effect of CXM was a result of its effect on the 
adrenal gland, because no retention deficits were found in 
CXM treated animals who had been adrenalectomized. Similarly 
Flexner & Flexner (1970) found injection of PUR into adre- 
nalectomized mice 1 hour after training did not impair reten- 
tion; however, when these mice were adrenalectomized after 
training there were retention deficits. The role of the 
pituitary-adrenal system in the memory process is further sup 
ported by findings which show corticosterone antagonized CXM 
induced amnesia when given immediately after training 
(Nakajima, 1975), or when given 13 or 16 hours after training 
(Flexner & Flexner, 1971). 
Nakajima (1976) believed a relationship existed between the 
level of corticosteroids and the degree of retention. That 
is, high levels of corticosteroids stimulate the corticoid 
receptors of the hippocampus, which causes an increase in 
adrenergic activity, and thereby promotes neural activity 
associated with retention. Whereas, low levels of corticos- 
teroids understimulate the corticoid receptors of the hippo- 
campus, which causes a decrease in adrenergic activity (i.e. 
neuronal blockage) and a negative effect on retention. 
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Biochemically, CXM reduces corticosteroid levels via its 
inhibitory effect on protein synthesis within the adrenal 
gland, and the decrease in corticosteroids stimulates a cor- 
responding increase in ACTH. ACTH acts in a feedback cycle 
with corticosteroids, in which low levels of corticosteroids 
stimulate the release of ACTH, and the increased level of 
ACTH stimulates the adrenal gland to release corticosteroids. 
The feedback system continues until an equilibrium is esta- 
blished between ACTH and corticosteroids (Langley, 1971). The 
rise in ACTH caused by CXM induced depletion of corticost- 
eroids does not stimulate an immediate rise in corticosteroid 
levels from the adrenal gland because the adrenal is unres- 
ponsive to ACTH as a result of the CXM treatment. For ACTH 
to counteract CXM's effect on the adrenal gland it must wait 
until the adrenal gland recovers from the effect of CXM. 
Once the adrenal gland recovers, it then responds to the high 
levels of ACTH, and thereafter the corticosteroid level is 
re-established. These changes stimulate adrenergic activity 
and promote transmission of neural memory impulses. 
Other experiments demonstrate that the effects of CXM on 
the adrenal gland and the effects of CXM on retention are 
dissociable. Squire, St. John & Davis (1976) found the 
injection of aminoglutethimide (50mg/kg), depleted as much 
corticosterone as did CXM (120mg/kg), but it did not impair 
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retention of a discrimination task when tested 5 days later. 
And they also found post training injections of corticos- 
terone (which was calibrated to offset the depletion caused 
by CXM) produced a more profound amnesic effect rather than 
being counteractive. Similarly, Dunn & Liebmann (1976) 
found injection of aminoglutethimide in mice 5 or 30 
minutes prior to training did not cause amnesia for passive- 
avoidance training when tested 24 hours later. And neither 
did the drugs dexamethasone (an inhibitor of ACTH secretion, 
which block corticosteroid secretion during training) and 
cortexdone (which competes with both cerebral and peripheral 
corticosterone receptors) impair retention when tested 24 
hours later. 
Apart from the effects on retention caused by either changes 
within the central nervous system, or within the peripheral 
nervous system is evidence suggesting an interaction exists 
between norepinephrine and the pituitary-adrenal axis in 
relation to learning and retention. Ogren & Fuxe (1974) found 
the combined insult of adrenalectomy and 6-OHDA lesioning 
of the dorsal CA bundle of the hippocampus impaired learning 
and retention (1 week after training) of a conditioned avoid- 
ance response task. Whereas, no deficits in learning and 
retention were found in rats that were only lesioned or 
adrenalectomized. Similar results were found by Mason, 
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Roberts & Fibiger {1979), when retention testing took place 
24 hours after training. Furthermore, this effect on lear- 
ning and retention was antagonized by corticosterone 
injections (Orgen & Fuxe, 1977). 
In another experiment, differences were found between the 
effects of the amnesic drug DDC and NE cortical lesioning 
plus adrenalectomy on acquisition and retention of an avoid- 
ance response task. In this experiment, rats were placed 
on a safe platform which was elevated from an electrically 
charged grid floor. Once the rat moved down onto the grid 
floor, it received shocks until it escaped back onto the 
safe platform. The findings demonstrated the rats with 
lesioning and adrenalectomy took longer to learn the task, 
and had greater retention deficits 24 hours after training; 
whereas, rats treated with only DDC learned the task normally, 
but displayed impaired retention 24 hours later (Roberts 
& Fibiger, 1977). These results are contradictory, because 
if DDC impaired retention as a result of inhibiting NE at 
time of retention test, then so should the 6-OHDA lesioning 
of NE (Ogren & Fuxe, 1974) cause similar retention deficits. 
However, this was not the case; possibly DDC has more of a 
non-specific effect (which has been suggested previously) 
and its effect differs significantly from 6-OHDA lesioning. 
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The major points brought out by experiments investigating 
the relation between protein synthesis inhibitors and 
amnesia are that the amnesic effects are more pronounced 
for long term retention than for short term retention, and 
that the impairment is temporary. The non-specific side 
effects of amnesic drugs on locomotor activity, and aversive 
conditioning are dissociable from the effect of these drugs 
on retention. The effect of these drugs on protein synthesis 
is not the only biochemical change, instead the effect of 
these drugs on adrenergic activity is also important. Adren- 
ergic stimulation enhances retention, whereas, adrenergic 
depression impairs retention. Other findings suggest CXM 
inhibits protein synthesis within the adrenal gland, and that 
subsequently, this lowers corticosteroids and neurotrans- 
mitter levels, which in turn induces memory blockage. How- 
ever, alternative findings suggest that either CXM's effect 
on the pituitary-adrenal system is dissociable from its 
effect on retention; or that an interaction exists between 
NE and the pituitary-adrenal axis in relation to learning 
and retention. 
18 
Rationale of the Experiment 
The purpose of the present experiment was to determine 
whether ACTH would counteract CXM's amnesic effect. 
ACTH was chosen for two reasons, First, ACTH enhances 
retention (Bohus, 1971; Gold & van Buskirk, 1976 a,b; 
King & de Wied, 1974; Sands & Wright, 1979) and this is 
thought to result from its facilitatory influence on the 
adrenergic system, i.e. ACTH increases the metabolism of 
NE and DA (Dunn & Gispen, referred from Dunn, 1980). 
Whereas, CXM impairs retention (Squire & Barondes, 1972) 
and this is thought to result from its inhibitory effect 
on adrenergic activity (Quartermain, Friedman, Botwinick & 
Gutwein, 1977). Therefore, if one can show that ACTH 
antagoizes CXM, then this would suggest that ACTH acted as 
an adrenergic stimulator. 
Second, this particular combination of drugs allows one to 
test whether CXM actually affects retention as a result of 
its influence on protein synthesis within the adrenal gland, 
as hypothesised by Nakajima (1976). 
Nakajima (1976) suggested that CXM has a peripheral effect, 
as opposed to a central effect on the nervous system. Inhi- 
bition of protein synthesis within the adrenal gland by CXM 
decreases corticosteroid release, and this leads to less 
stimulation of the corticoid receptors of the hippocampus 
and subsequent reduction of the adrenergic neurotransmit- 
ter substances NE and DA. Preventing the release of NE 
and DA causes neural blockage of memory impulses and reten- 
tion impairment. Once the effects of CXM expire and the 
adrenal gland recovers, then ACTH (which was elevated in 
response to low levels of corticosteroids) begins to stimu- 
late the release of corticosteroids. 
The part of Nakajima's hypothesis that is not clear, involve 
the question of why ACTH, which is released in response to 
CXM induced depletion of corticosteroids, does not directly 
stimulate the adrenergic system at the same time that CXM 
is inhibiting it, such counteraction should negate the 
amnesic effect of CXM. In this way, ACTH would be exerting 
its influence via the central nervous system, instead of 
through the pituitary-adrenal system. Therefore the argu- 
ment of whether CXM causes amnesia as a result of its effect 
on the adrenal gland would be questionable. 
To answer the question of whether CXM affects retention as 
a result of its effect on the pituitary-adrenal system, one 
would have to test the interaction of exogenous ACTH on 
CXM. If exogenous ACTH does not antagonize CXM, then this 
would suggest that ACTH exerts its influence via the 
adrenal gland, and is without effect until the adrenal 
gland recovers from CXM treatment. 
On the other hand, if the exogenous injection of ACTH 
does counteract CXM's amnesic effect, then this would 
suggest that ACTH had a central effect on the adrenergic, 
system - independent of any effect on the adrenal gland. 
Therefore, one would not suspect CXM's effect on the 
corticosteroid levels to be the cause of the amnesia. If 
CXM did significantly inhibit the release of corticoste- 
roids, then there would be a corresponding internal rise 
in ACTH, and together these substances would counteract 
each other's affect on the adrenergic system. Hence, 
there would be no effect on retention. 
This present research may clarify the argument over 
the cause of CXM's amnesic effect. Nakajima argues that 
amnesia results from CXM's inhibitory effect on corticost- 
eroid levels; whereas, Squire, St. John & Davis (1976) 
and Dunn & Liebmann (1976) argue that CXM's effect on 





Eighty 100 day old, experimentally naive rats (50 male 
and 30 female) , from the SHS genetic line were used as 
subjects. This line is a genetically heterogeneous stock 
derived from a four-way cross among the selected lines 
(Roman high and low avoidance, and Maudsely reactive and 
non-reactive, see Satinder 1980 a, for details). The 
animals were bred and reared in the laboratory and weaned 
at 28 days of age. Before experimentation the animals 
were housed by groups of two of the same sex. During the 
course of the experiment the animals were coded and housed 
in individual cages on the same rack. The laboratory 
temperature was thermostatically controlled at 22+ 1°C. 
Humidity level was maintained at 40%, and the fluorescent 
lighting was on a 12:12 hour light/dark cycle. Rats were 
tested in the light cycle. 
Experimental Design 
The experimental design was a 5 (drug groups) x 2 (time of 
testing) complete factorial, 8 animals in each factorial 
cell with a repeated measure (training and retention test). 
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The 5 drug groups are outlined in Table 1. 
TABLE 1 
Experimental Design 
Group Pre- No. at Post- No. at 
training Training training Retention Test 
Treatment Treatment 1 hour 5 hours 
1 NaCl 16 
2 CXM 16 
3 ACTH 16 
4 CXM+ACTH 16 
5 CXM 16 
None 8 3 
None 8 8 
None 8 8 
None 8 8 
ACTH 8 8 
Group 1 animals received physiological saline injections 
before training, and acted as the control group. Group 2 
animals received CXM injections before training in order 
to test whether CXM would impair retention. Group 3 
animals received ACTH injections before training in order 
to test whether this drug would enhance retention. Group 4 
animals received both CXM and ACTH injactions before 
training in order to test whether the facilitatory effects 
of ACTH on adrenergic activity would counteract the inhi- 
bitory effect of CXM on adrenergic activity, and thereby 
protect against CXM-induced amnesia. Group 5 animals 
received CXM injections before training and ACTH injections 
immediately after training in order to test whether ACTH's 
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effect on adrenergic activity would counteract CXM's 
inhibitory effect on the adrenergic system. In this group 
ACTH would be present only during initial memory proc- 
essing, as opposed to being present in conjunction with 
CXM during acquisition as in group 4. 
All drugs were administered interperitoneally, and the time 
of administration was the same for all animals according 
to drug conditions (see Appendix I for drug administration 
schedule). CXM was injected 30 minutes prior to training 
for two reasons. First, CXM is most effective as an amnesic 
agent when given between 10 minutes and 5 hours before 
training (Classman,1969). Secondly, this time allowed for 
the effect of hyperactivity, which is associated with in- 
itial injection of CXM, to subside before training began 
(Segal, Squire & Barondes, 1971). 
The dosage level of CXM was 2.5 mg/ml/kg (Schmaltz & Clement 
-Forestier,1977), and the dosage level of ACTH was 4 lU/kg. 
Each rat weighed approximately 250 grams, therefore the 
dosage level of ACTH was equal to the level used by Sands 
& Wright (1979) who found that 1 lU/rat ACTH enhanced 
retention in rats. 
Retention was tested either 1 or 5 hours after training. 
Previous research shows that CXM impairs retention 3 to 
24 hours after training, but not during the first 3 hours 
past training (Classman, 1969). 
Prior to either training or injection the rats were indivi- 
ually tested for unconditional escape response (UER) 
in order to determine the minimum but effective level of 
electric shock necessary to make each animal respond equally 
because the SHS genetic strain is a heterogeneous strain 
derived from genetic lines that are known to have differ- 
ent UERs (Satinder,1976). Therefore, these differences may 
have transferred to the SHS genetic strain, and thereby 
causing individual differences for UER. 
The learning task used to test retention was a one-way 
jump-up paradigm in which animals avoided an electric 
shock, as unconditional stimulus (US) in response to an 
auditory conditioned stimulus (CS), by moving from an elec- 
trically charged grid floor on to a safe platform. A pilot 
study was carried out to determine the appropriate number 
of training trials needed to train the animal to learn 
the task at approximately 50% success level (i.e., 5 or 
more avoidance responses out of 10 trials). Retention was tested 
1 or 5 hours after training by means of an extinction schedule 
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(details reported later). Extinction was used because the 
jump“up learning task is an easily learned task (Satinder, 
1977), and for this reason it would be difficult to dis- 
sociate new learning from memory. Therefore, by using an 
extinction schedule confounding by new learning was avoided. 
The behavioral measures used were ones most clearly asso- 
ciated with the learning task. The selection of the learn- 
ing task was based on previous research showing that 
animals could learn the task relatively easily during one 
training session (Satinder & Petryshyn, 1974; Satinder, 
1977). The response measures were as follows : number of 
avoidance responses, i.e., the number of times the animal 
responded to the auditory stimulus and avoided electric 
shock ; and total response latency, i.e., the total time 
taken by an animal to avoid the auditory stimulus and/or 
escape from the shock (total response latency was taken 
because normally response latency measure is taken either as 
an avoidance response or an escape response latency, since 
the extinction schedule was used in this research there was 
no shock given during retention test, hence there could be 




The unconditional escape response (UER). The apparatus 
used to test UER was a circular Plexiglas runway 12 cm 
wide and 15 cm high with an outside circumference of 220 cm, 
which could be divided into 4 equal compartments by gui- 
llotine doors. The runway floor was constructed of 0.25 cm 
diameter stainless steel rods spaced 1 cm apart (center to 
center). A scramble shock could be delivered to the grids, 
and a digital clock was used to record response latencies 
(Satinder, 1980 b). 
One-way jump-up learning. The jump-up apparatus was a 
Lafayette A^586 (85204) unidirectional avoidance system 
for rats. It consisted of a chamber 265 x 200 x 200 mm 
made from anodized aluminum and 6 mm thick clear Plexi- 
glas , with 5 mm thick grid bars spaced 10 ram apart. On 
one side of the chamber was a platform 125 mm high, 200 mm 
wide, and 137 mm deep. The platform was elevated 80 mm 
from the floor level of the grid (Satinder and Petryshyn, 
1974) . 
A sound source (speaker) was placed next to the jump-up 
learning apparatus, which was used to produce a 70-db, 
9 KHz pure tone as CS against a background noise of 40 db 
(sound intensity was measured at the floor level above the 
standard reference level of .002^bar by a General Radio 
sound level meter. Type 1551-C). 
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Procedure 
Unconditional escape response (UER) . For UER testing each 
animal was individually adapted to the circular runway for 
1 minute period prior to receiving foot shock. Electric 
shock was administered until the animal escaped within 5 
seconds by running a distance equivalent to a quarter 
length of the runway (all doors open) in either direction, 
and this was defined as UER. Each animal was given 10 
trials of the ascending series by using the method of limits, 
with an intertrial interval of approximately 5 seconds. 
Shock intensities ranged between 0.27 to 0.97 ma (cali- 
brated with the assumption that the animal contributed 47k 
resistance). The lowest number of ma necessary to elicit 
UER was used as the appropriate US during training (Sat- 
inder/ 1977). 
Learning: Training and retention test. Each experimental 
day was arranged in a specific pattern to allow for the 
synchronous training and testing of all animals individually 
(see Appendix I for experimentation schedule). Ten animals 
were trained and tested each day, and of these 10 two were 
randomly assigned to each of the five drug groups. Within 
each drug group, one of the animals was tested for retention 
1 hour after training, and the other animal 5 hours after 
training. 
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All injections were.given 30 minutes before training - 
except for animals of group 5 which received additional ACTH 
injections immediately after training. After the injection 
the animal was returned to its home cage, and 30 minutes 
later the animal was trained in the one-way jump-up learning 
apparatus (see Appendix 1 for training timetable). 
During training the CS was presented for 10 seconds followed 
by 10 seconds of CS and US. The safe platform was exposed 
at the time CS started. To avoid the US, the animal had to 
jump onto the safe platform within the 10 seconds of CS. If 
the animal jumped then the CS was discontinued, and the 
animal was allowed to remain on the platform for the remain- 
ing duration of CS and intended US (i.e., 20 seconds minus 
response time). If the animal did not respond during CS, 
but it did escape in response to the US (in conjunction with 
the CS) then it was allowed to remain on the platform for the 
duration of the remaining US interval. After the CS and 
the US interval ended, the animal was pushed back on to the 
safe grid floor of the apparatus (provided the animal did 
escape) and the platform door was closed. The animal re- 
mained on the safe grid floor for the intertrial interval 
averaging 40 seconds, at which time the next training trial 
began. Ten training trials were given to each animal. 
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Immediately after training the animal was taken back to its 
home cage - except if the animal belonged to group 5, and 
in that case the rat was injected with ACTH and then returned 
to its home cage. An hour later, one of the two animals 
from each drug group was removed from its cage and placed 
in the one-way jump-up apparatus and tested for retention 
(see Appendix 1 for the timetable of testing times for those 
animals of the different drug groups tested 1 hour after 
training). 
The extinction schedule used to test retention was identical 
to the training procedure except that the US (i.e., electric 
shock) was eliminated. The rat was presented with the sound 
source for a 20 second period during which time it was 
allowed to jump onto the safe platform. This extinction 
schedule tested whether the animals associated the condi-: 
tioned tone with the electric shock, previously given, and 
as such avoided the grid floor by moving onto the safe 
platform in response to the CS tone. 
After a period of 5 hours past training the second animal 
from each drug group was removed from its home cage and placed 
in the one-way jump-up apparatus and tested for retention. 
(See Appendix I for appropriate time table for testing). The 
same extinction schedule was used and the same two behavioral 
measures were recorded. 
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RESULTS AND DISCUSSION 
Preliminary analysis of variance revealed no sex differ- 
ences hence the data for both sexes were pooled for fur- 
ther analysis. 
The mean number of avoidance responses (Figure 1) and the 
measure of response latency (Figure 2) are presented 
below for each of the tv7o test groups (i.e. drug groups 
tested 1 hour, and tested 5 hours after training) within 
each of the 5 drug groups during both training and retent- 
ion test. 
LJ Training 
^3 Retention Test 
FIGURE I; Mean number of avoidance responses 
groups tested -i and 5 hours after 






DRUG GROUPS DRUG GROUPS 
FIGURE 2: Mean response latency for the drug groups tested 
1 and 5 hours after training during both training 
and retention. 
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A 5 (drug groups) x 2 (test group) x 2 (training and 
retention test) complete factorial analysis of variance 
revealed significant main effects for test groups (number 
of avoidance responses F=6.7, df=l/70, P<.01; response 
latency, 01). That is, groups tested 5 hours after 
training had significantly lower number of avoidance 
responses and higher response latencies than groups tested 
1 hour after training. Also, the difference between 
training and retention test scores were significant (number 
of avoidance responses, P<.01; response latency, PC.01). 
That is, the animals responded with fewer avoidance res- 
ponses and longer response latencies during retention test, 
than at the time of training. 
During training, there were no significant differences 
among the five drug groups in either of the response mea- 
sures. Similarily, during training differences between 
drug groups tested 1 hour and 5 hours after training were 
also non-significant. These findings suggest that the 
drug and test groups were homogeneous at time of training. 
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During retention test, there were no significant 
differences among the 5 drug groups when tested either 
1 or 5 hours after training. 
In retention test, within each of the drug groups the 
differences between groups tested 1 hour after vs 5 
hours after training were significant in only the CXM 
drug group (number of avoidance responses F = 7.2, 
df = 1/14, P < .01; response latency, p .01). These 
findings suggest CXM impaired retention 5 hours after 
training, which confirms other experimental findings 
that have also shown CXM’s suppressive effect on long 
term retention (Schmaltz & Delerm, 1974; Squire & 
Barondes, 1972) . However, ACTH was not found to 
enhance retention, which is in contrast to the findings 
by Gold & van Buskirk (1976 a,b) and by Sands & Wright 
(1979), who found that ACTH enhances retention. Why 
ACTH by itself did not influence retention in the 
present experiment may be partially explained by the 
fact that ACTH was given to Group 3 before training, 
whereas in the other experiments ACTH was given after 
training. In addition, the fact that the control 
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group showed no significant differences between testing 
1 or 5 hours after training suggests that the time factor 
for retention test is not solely responsible for any 
difference found within other drug groups. 
Changes in scores from training to retention test were not 
significantly different among drug groups tested 1 hour 
after training. But these changes were significantly differ- 
ent among groups tested 5 hours after training (number of 
avoidance responses F=26.7, df=l/34, p<C.01; response 
latency, P<*. 01). In particular, these differences were 
evident in the CXM and the CXM+ACTH (in this latter group 
ACTH was given before training to CXM treated animals) 
drug groups on the number of avoidance responses (F=5.4, 
min 
df-1/6, P<*. 01) and on the response latency (P<*. 01) 
Interestingly, a test of interaction-for the change from 
training to retention test (5 hours past training) between 
the CXM+ACTH group, and the CXM-ACTH group (in this drug 
group ACTH was injected into CXM treated rats immediately 
post training) revealed non-significant for both behavioural 
measures. The previously mentioned differences found in the 
within drug group analysis for the CXM+ACTH group can be 
accounted for by the fact that the rats in this drug group 
had higher response levels at time of training, than the rats 
of the CXM-ACTH drug group, and this made the change from 
training to retention test appear significant, where in 
reality, it was not. Hence, the result of no interaction 
indicates ACTH was successful in reversing the amnesic 
effect of CXM, regardless of it being injected before or 
immediately after training. 
There are three important findings revealed by the analysis. 
First, the results support previous findings which have 
demonstrated CXM's amnesic effect on long term retention, as 
opposed to short term retention (Schmaltz & Delerm, 1974; 
Squire & Barondes, 1972). Second, the effect of ACTH admin- 
istered before training did not affect retention. Third, 
the effect of giving ACTH before training or immediately after 
training to CXM treated animals counteracted the amnesic 
effect of CXM on retention. This is demonstrated by the lack 
of significant change in the number of avoidance responses 
or response latency from training to retention test 5 hours 
after training. These results are interesting because they 
suggest that the stimulating effect of ACTH on the adren- 
ergic system is important during acquisition of the avoidance 
task and important at the time of initial memory processing 
in order to successfully counteract CXM induced amnesia. 
The present findings help to clarify whether CXM impairs 
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retention as a result of its inhibitory effect on corticos- 
teroid levels, as suggested by Nakajima (1976). He believed 
that a causal relationship existed between corticosteroids 
and retention, i.e. low levels of corticosteroids cause re- 
tention deficits. His findings (1975) showed that CXM did 
not impair retention in adrenalectomized rats and therefore 
he concluded that the mechanism affected by CXM must reside 
within the adrenal gland. He hypothesized that CXM caused 
protein synthesis inhibition within the adrenal gland, and 
this caused a decrease in corticosteroid release, which in 
turn reduced stimulation of the adrenergic system, hence 
memory blockage. Further experimentation confirmed his 
beliefs as to the role of corticosteroids on retention. He 
found that the exogenous injection of corticosteroids count- 
eracted CXM's suppressive effect on retention. 
Arguments against Nakajima’s theory arise from experimental 
findings that do not show a causal relationship between low 
corticosteroid levels and impaired retention. In specific. 
Squire, St. John & Davis (1976) reported that CXM induced 
amnesia could not be prevented even though corticosteroid 
levels were experimentally maintained; and similarly, Dunn 
& Liebmann (1976) found they could not induce a CXM like 
amnesia by using a drug that caused no protein synthesis 
inhibition, but did cause a decrease in corticosteroid re- 
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lease. Dunn (1981) argues that it is unlikely CXM's 
peripheral effect is the cause of amnesia (as proposed by 
Nakajima, 1975) because higher drug concentrations are 
needed when the administration is peripheral, as opposed to 
being central. 
The results of the present research demonstrate that when 
ACTH was injected before or immediately after training to CXM 
treated animals the amnesic effect of CXM on retention was 
suppressed. The implication of this finding is that CXM 
does not affect retention when there are high levels of ACTH. 
And in turn, this suggests that CXM's effect on retention is 
independent of its effect on the pituitary-adrenal system. 
The biological system disrupted by CXM is thought to be the 
adrenergic system because experiments have shown that a 
relationship exists between the level of neurotransmitter 
substances (NE and DA) and the effect on retention. Stimu- 
lation of the adrenergic system prevents CXM induced amnesia 
(Quartermain, et. al. 1977); and the inhibition of the adren- 
ergic system produces a CXM like amnesia (Quartermain & 
Botwinick, 1975). Hence, CXM affects retention as a result of 
its suppressive effect on adrenergic activity. Based on this 
premise it is argued that ACTH acted in a similar manner as 
the other adrenergic stimulators, and thereby compensated for 
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CXM induced depletion of NE and DA. This interpretation is 
consistent with views put forward by Flood, et. al., (1978), 
Dunn & Gispen (1977; referred from Dunn, 1980) who suggest 
that ACTH directly stimulates neural activity. 
If CXM does exert its amnesic effect via the pituitary- 
adrenal system, as suggested by Nakajima (1975), then one 
would expect the subsequent increase in the ACTH level, 
resulting from CXM's inhibition of corticosteroid release, 
to counteract the amnesia similar to the way exogenous ACTH 
antagonized CXIA in the present research. This is obviously 
not the course of events because CXM does impair retention, 
therefore CXM must not significantly affect the pituitary- 
adrenal system. 
In contrast to the above-mentioned suggestion that CXM's 
effect on the adrenal gland is dissociable from its effect on 
retention is evidence showing that a relation exists. 
Neither adrenalectomy, nor lesioning of cortical NA bundle 
disrupted retention itself; but the combined operations did 
(Ogren & Fuxe, 1974, 1977; Mason, Roberts & Fibiger, 1979). 
Thus suggesting CXM impairs retention by simultaneously 
affecting norepinephrine and the pituitary-adrenal axis. The 
relation of these findings to the present experiment is that 
ACTH antagonized CXM induced amnesia by disruptiong CXM's 
total effect, i.e. , ACTH counteracted CXM's effect on NE, but 
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not its effect on the pituitary-adrenal axis. Accordingly, 
one would not expect the disrupted pituitary-adrenal axis 
to impair retention by itself. Therefore, the synergistic 
effect of NE inhibition and adrenal inhibition may be 
responsible for CXM induced amnesia. 
One question that does arise is whether the dosage level 
of ACTH given was the appropriate dosage to completely 
antagonize CXM. Future experimentation may test whether 
varying the dose of ACTH affects CXM's amnesic effect any 
differently during training or retention test. Furthermore, 
the fact that ACTH reversed CXM induced amnesia when given 
before training, and when given immediately after training 
is contradictory to other experimental findings which show 
adrenergic stimulation (by giving amphetamine) immediately 
after training counteracts CXM, whereas pretraining injections 
do not (Quinton & Bloom, 1975; Bloom, 1975). 
Stimulation of the adrenergic system as a result of high 
levels of ACTH aids the memory process against the influence 
of CXM. Gibbs & Ng (1977) suggest that there are three 
stages involved in the memory process - a short term phase, 
a labile phase, and a long term phase. Proper transition 
from the short term phase to the long term phase requires 
that the intermediary labile phase not be interrupted. This 
labile phase is vulnerable, and as such, any changes in the 
biochemical system during this phase will disrupt it. How- 
ever, the short term and the long term phases are more 
stable, and are not atfected by the same biochemical change 
Therefore, depletion of the neurotransmitter substances by 
CXM causes neural blockage, and this interference disrupts 
the labile phase. As the neurotransmitter levels are re- 
stored, so is the recovery of the memory process. In the 
present research one can interpret the results by saying 
that the post training injections of ACTH adequately stimu- 
lated the adrenergic system, which in turn compensated for 
CXM induced depletion of NE and DA. This compensation 
prevented interference to the labile phase, and as such, 
allowed for normal memory processing. 
In conclusion, the present research brings out three points 
First, injection of ACTH 30 minutes before, or immediately 
after training counteracted CXM induced amnesia. Second, 
CXM's inhibitory effect on corticosteroid levels is dis- 
sociable from CXM’s effect on retention. Third, normal 
levels of neurotransmitter substances must exist at time of 
initial memory processing to prevent CXM from interfering 
with the labile phase of the memory process. 
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